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Gene-expression changes observed in Drosophila embryos after inducing the
transcription factor Tramtrack led to the identiﬁcation of the protein Expansion.
Expansion contains an N-terminal domain similar in sequence to the MH2
domain characteristic of Smad proteins, which are the central mediators of the
effects of the TGF- signalling pathway. Apart from Smads and Expansion, no
other type of protein belonging to the known kingdoms of life contains MH2
domains. To compare the Expansion and Smad MH2 domains, the crystal
structure of the Expansion domain was determined at 1.6 A˚ resolution, the ﬁrst
structure of a non-Smad MH2 domain to be characterized to date. The structure
displays the main features of the canonical MH2 fold with two main differences:
the addition of an -helical region and the remodelling of a protein-interaction
site that is conserved in the MH2 domain of Smads. Owing to these differences,
to the new domain was referred to as N-MH2. Despite the presence of the
N-MH2 domain, Expansion does not participate in TGF- signalling; instead,
it is required for other activities speciﬁc to the protostome phyla. Based on the
structural similarities to the MH2 fold, it is proposed that the N-MH2 domain
should be classiﬁed as a new member of the Smad/FHA superfamily.
1. Introduction
The Drosophila transcription factor Tramtrack (Ttk) is
involved in a wide range of processes during development of
the tracheal system. The analysis of gene-expression changes
in Drosophila embryos after inducing Ttk loss of function and
gain of function enabled the identiﬁcation of the Expansion
gene (CG13188; Exp). A search for similar proteins to
Expansion led to the identiﬁcation of CG13183 (recently
renamed Rebuf; Reb; Rotstein et al., 2011). These two
proteins share 56% amino-acid similarity that is concentrated
in the N-terminal part of the sequence. Expansion and Rebuf
(Exp/Reb) proteins have been identiﬁed in severalDrosophila
species, other insects and arthropods (Iordanou et al., 2014).
They are annotated in the NCBI database as modular proteins
containing an N-terminal MH2 domain and a variable
C-terminal region which does not present sequence similarity
to other characterized domains. The sequence similarity to the
MH2 domain is quite remarkable since these domains were
believed to be exclusively present in Smad proteins, which
are the main players in the TGF- signalling pathway in
metazoans (Massague´, 2012). Smad proteins comprise two
conserved domains separated by a linker that does not adopt
a deﬁned tertiary structure. The N-terminal (MH1) domain
binds to DNA sites in promoters, while the linker and the
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C-terminal (MH2) domain are the protein-interaction sites. As
mediators and regulators of cytokine signalling, Smads are
involved in many cellular processes from cell homeostasis to
differentiation, division and cell death (Massague´ et al., 2005).
The presence of an MH2 domain in Exp/Reb proteins has
been used as a hallmark to classify them as Smad-like proteins
(Iordanou et al., 2014). However, the sequence identity of the
Exp/Reb proteins to the Smads is very low and is restricted to
the MH2 domain. Furthermore, the differences are not only at
the sequence level but also in the localization of the domain:
in the N-terminal part in Exp/Reb in contrast to a C-terminal
position in Smads. Secondary-structure predictions indicate
that the Exp/Reb MH2 domain might contain additional
elements of secondary structure preceding the MH2 fold. All
of these characteristics suggest that Exp/Reb might constitute
a new family of proteins that share the presence of a divergent
MH2 domain with the Smads.
To clarify this issue and prompted by the similarities and
differences between the Exp/Reb and Smads proteins, we set
out to investigate the presence of the Exp/Reb proteins in
metazoans and to characterize the structure of this new
MH2 domain. Our results reveal that Exp/Reb proteins
are restricted to protostomes, whereas Smads are highly
conserved in both protostomes and deuterostomes. Regarding
the structure, the crystal structure of this domain has been
determined at 1.6 A˚ resolution and represents the ﬁrst struc-
ture of an MH2 domain to be deﬁned outside the Smad family
of proteins. Although the structure displays the main features
of the MH2 fold, it contains an additional -helical region that
covers the concave site of the MH2 domain and deﬁnes the
speciﬁc structure of the Exp/Reb MH2 domain. Based on this
observation, we refer to the Exp/Reb MH2 domain as an N-
MH2 domain, a new member of the FHA/Smad superfamily of
MH2 domains.
A characteristic of activated Smad proteins is the formation
of quaternary structures through interactions of their MH2
domains (Shi & Massague´, 2003). Even if Exp/Reb proteins
are different from Smads, the presence of the N-MH2
domain led us to hypothesize that Exp/Reb proteins could
perhaps also modulate TGF- signalling in protostomes
through the formation of heterotrimers using the N-MH2
domain as a binding partner for Smads. The functional and
structural studies presented here support the nonparticipation
of Expansion in the canonical TGF- signalling pathway.
Analysis of the N-MH2 structure and its comparison with
those of Smad proteins provides the basis for understanding
the binding differences. Our data are in agreement with the
results reported in the literature indicating that Exp/Reb
proteins are required for speciﬁc activities in protostomes,
regulating receptor tyrosine kinase signalling to control
terminal branch size and morphology (Iordanou et al., 2014).
2. Experimental procedures
2.1. Sequence alignment and secondary-structure prediction
Sequences corresponding to Expansion proteins were
retrieved from the Ensembl Metazoa database (http://
metazoa.ensembl.org) with PSI-BLAST (Altschul et al., 1990),
using the D. melanogaster Expansion protein (CG13188) as
the query. Multiple sequence alignments with the query and
the target proteins were generated with MAFFT v.7.164b
using the iterative L-INS-i method (parameters: Blosum62
scoring matrix and gap-opening penalty set to 1.5).
Conserved residues were highlighted using the BoxShade
server v.3.21 (http://sourceforge.net/projects/boxshade/)
written by K. Hofmann and M. Baron. A graphical repre-
sentation of secondary structure was added to the alignment
using the ESPript server (Robert & Gouet, 2014).
Prediction of secondary-structure content was performed
using the online version of NetSurfP (http://www.cbs.dtu.dk/
services/NetSurfP/; Petersen et al., 2009).
2.2. Cloning of the Expansion Na-MH2 domain
Constructs for the Expansion domain were cloned into the
pETM-11 expression vector (EMBL) by means of ligation-
independent cloning. The initial construct used for NMR
screening and preliminary crystallization trials consisted of a
fragment comprised of residues 29–240. We also prepared a
second construct including an N-terminal extension (residues
3–240), which was used for structural studies.
Inserts were obtained by PCR using the appropriate
primers and theD. melanogaster Expansion cDNA (CG13188,
isoform B) as a template. PCR ampliﬁcation was carried out
using the standard PCR Master Mix with 0.02 unit ml1 Taq
DNA polymerase (Thermo Scientiﬁc), 1 ng ml1 template
DNA and 0.5 mM of each primer, using an annealing
temperature of 321 K for the ﬁrst ten rounds and 341 K for the
last 30 rounds. After subsequent puriﬁcation of the reaction
product using the GeneJET PCR puriﬁcation kit (Fermentas),
ligation-independent cloning was performed in the presence
of 6 mg ml1 RecA DNA recombinase in the recommended
buffer (New England Biolabs) at 310 K for 15 min. The full
recombination reaction was then used for transformation in
E. coli DH5 and positive clones were selected on kanamycin
agar plates (50 mg ml1). Positives clones were veriﬁed by
DNA sequencing and subsequently transformed into the
expression strain E. coli BL21 (DE3) Rosetta (Invitrogen),
selecting positive clones on kanamycin (50 mg ml1) + chlor-
amphenicol (34 mg ml1) agar plates.
2.3. Protein expression and purification
Cultures were grown at 310 K until an OD of 0.6 was
reached; the temperature was then lowered to 293 K and
protein expression was induced by the addition of 1 mM
isopropyl -d-1-thiogalactopyranoside (IPTG). Expression
took place for 12–15 h and the cells were harvested by
centrifugation (4000g, 15 min). Labelled samples for NMR
were prepared in a similar manner using minimal medium
(M9) enriched with 15NH4Cl.
The cells were washed in TBS buffer and 5 g of cells were
resuspended at 277 K in 10 ml buffer consisting of 50 mM
Tris–HCl pH 7.2, 500 mM NaCl, 1 mM phenylmethylsulfonyl-
ﬂuoride (PMSF), 0.1 mM -mercaptoethanol (BME), 0.1 mM
research papers
Acta Cryst. (2015). D71, 844–853 Beich-Frandsen et al.  Expansion 845
electronic reprint
EDTA supplemented with 0.1 mg ml1 lysozyme,
0.25 mg ml1 DNaseI, 25 mM MgCl2, 0.01 mg ml
1 RNaseA
for lysis. Lysis was performed in a pressurized cell homo-
genizer at 277 K and the crude solution was incubated for
20 min on ice. The soluble fraction was then isolated by
centrifugation (45 000g, 20 min, 277 K).
Immobilized metal-ion afﬁnity chromatography (IMAC)
was performed on an A¨KTA FPLC system at room
temperature using a prepacked 1 ml His-tag column (GE
Healthcare). The domain of interest was puriﬁed using buffer
consisting of 50 mM Tris–HCl pH 7.2, 500 mM NaCl, 0.1 mM
BME, 0.1 mM EDTA and eluted with a gradient to the same
buffer freshly supplemented with 500 mM imidazole (50 mM
Tris–HCl pH 7.2, 500 mM NaCl, 0.1 mM BME, 0.1 mM
EDTA, 500 mM imidazole). Peak fractions were isolated and
diluted with buffer (50 mM Tris–HCl pH 7.2, 200 mM NaCl,
0.1 mM BME) to lower the salt and imidazole concentrations
for enzymatic digestion. Subsequently, the N-terminal 6His
tag was removed by overnight digestion at 277 K with Tobacco
etch virus (TEV) protease and the digested protein was
repuriﬁed by IMAC as described above. Size-exclusion chro-
matography (SEC) was performed on a Superdex 200 10/300
column using buffer consisting of 50 mM Tris–HCl pH 7.2,
200 mM NaCl, 0.1 mM BME and the peak fractions were
collected and concentrated to 10 mg ml1 using centrifugal
ﬁlters (Amicon).
2.4. Drosophila strains and genetics
The ﬂy strains used are described in FlyBase.
Df(2R)ED2247 and Df(2R)BSC879 uncover CG13188 and
CG13183 and were used in transheterozygous conditions
to analyze the absence of both genes (CG13188+CG13183
mutants). The transgenes used were P(TRiP.HMS01445)attP2
(UAS13188RNAi), P(TRiP.HMS01444)attP2 (UAS13183RNAi),
P(TRiP.JF02218)attP2 (UASMedRNAi), UASDad and
UASTkvCA.
For overexpression experiments, we used the Gal4/UAS
system (Brand & Perrimon, 1993). We used the breathlessGal4
(btlGal4) driver, which drives expression in all tracheal cells,
and the nubbinGal4 (nubGal4) driver, which drives expression
in the wing disc. Crosses were kept at 29C to maximize the
expression of the transgenes.
To visualize the ‘tracheal pattern’, the embryos carrying
btlGal4 UAS-srcGFP (cell membrane staining) were stained
for GFP. The bltGal4 in this combination also drives the other
UAS transgenes.
Confocal images were acquired with a Leica TCS-SPE
system. Images were post-processed with ImageJ and Adobe
Photoshop and assembled using Adobe Illustrator.
2.5. NMR experiments
An HSQC (heteronuclear single-quantum coherence)
NMR experiment (eight scans and 128 increments in the
indirect dimension) was recorded at 298 K on a Bruker
Avance III 600 MHz spectrometer equipped with a z-pulse
ﬁeld gradient unit and a triple (1H, 13C, 15N) resonance probe
head. The protein sample (0.7 mM) was equilibrated in 20 mM
deuterated Tris–HCl, 150 mM NaCl buffer with 10% D2O and
the pH adjusted to 7.5. The data were processed using the
XwinNMR 3.5 software supplied with the Bruker NMR
spectrometer.
2.6. Crystallization
Initial crystallization conditions were identiﬁed from
sparse-matrix screens. A series of gradient screens optimized
the ﬁnal condition and three-dimensional diffraction-quality
crystals were ﬁnally grown in sitting drops at 293 K from
12%(v/v) 1,2-propanediol, 9%(w/v) PEG 20 000, 0.1M
glycine pH 9. The short protein construct crystallized in similar
conditions.
2.7. Data collection
Data were collected at 100 K from a monoclinic crystal
using a PILATUS 6M detector on BL13-XALOC at the
ALBA Synchrotron Light Source, Barcelona, Spain. 360
images were collected at a wavelength of 0.97949 A˚ with an
exposure time of 1 s and an oscillation of 1. Data were
processed in theXDS suite (Kabsch, 2010) and validated using
research papers
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Table 1
Data-collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
Beamline XALOC, ALBA
Wavelength (A˚) 0.979
Resolution (A˚) 31.3–1.59 (1.63–1.59)
Space group P21
Unit-cell parameters (A˚, ) a = 36.8, b = 45.7, c = 54.2,
 = 90.00,  = 93.31,  = 90.00
Molecules per asymmetric unit 1
Unique reﬂections 23152 (2902)
Completeness (%) 95.5 (74.6)
Rmeas† 0.071 (0.983)
Rmerge‡ 0.069 (0.840)
Multiplicity 5.89 (3.5)
hI/(I)i 13.6 (1.1)
CC1/2§ 0.998 (0.506)
BWilson (A˚
2) 33.0
Rwork/Rfree} 0.176 (0.323)/0.198 (0.350)
Average B factor (A˚2)
Protein 32.9
Water 38.9
R.m.s. deviation from ideal values
Bond lengths (A˚) 0.019
Bond angles () 1.462
Ramachandran plot statistics (from MolProbity††)
Outliers (%) 0
Favoured (%) 98.2
MolProbity‡‡ statistics
Score 1.35
Clashscore 6.26
Rotamer outliers (%) 1.0
No. of atoms (non-H) 1740
No. of solvent molecules 75
PDB code 4r9p
† Rmeas =
P
hklfNðhklÞ=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
‡ Rmerge is deﬁned according to Kabsch (2010). § CC1/2 is the correlation between
intensities from random half data sets (Karplus & Diederichs, 2012). } Rfree is the
cross-validation R factor computed for a test set of reﬂections (5%) which were omitted
from the reﬁnement process. †† R.m.s. deviation from ideal values in accordance with
Engh & Huber (2001). ‡‡ Chen et al. (2010).
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POINTLESS (Evans, 2006). Statistics of data-collection and
model building are presented in Table 1.
2.8. Phasing, model building and refinement
Structure solution and model reﬁnement was performed
with programs from the PHENIX suite (Adams et al., 2010).
A structural solution was obtained by molecular replacement
with Phaser (McCoy et al., 2007) in the phenix.mr_rosetta
pipeline of programs (DiMaio et al., 2009; Terwilliger et al.,
2012), using as a search model an ensemble constructed from
the known structures of canonical MH2 domains: PDB entries
1khx (16% sequence identity; Wu et al., 2001), 1mjs (16%; Qin
et al., 2002), 1khu (15%; Qin et al., 2001), 1dd1 (15%; Qin et
al., 1999) and 3gmj (14%; Wang et al., 2009).
Sequence alignment and selection of homologues was
performed with HHpred (So¨ding et al., 2005), and Sculptor
(Bunko´czi & Read, 2011) was used to edit non-identical
side chains (Schwarzenbacher et al., 2004), subsequently
superimposing the structures in Ensembler, which also
research papers
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Figure 1
Sequence alignment of the N-terminal region of Expansion and Smad MH2 domains. (a) Sequence alignment of the N-terminal region of the
D. melanogaster Expansion protein with orthologous proteins found in the Hexapoda, Arthopoda and Nematoda phyla. These sequences were obtained
using BLAST. Using a PSI-BLAST search, we also detected sequence similarity to the MH2 domain of Smads. TheHomo sapiens andDrosophila Smad2
MH2 domains are included in the alignment for comparison. Additional entries corresponding to uncharacterized proteins were not included in the
alignment. A sequence alignment of the full-length proteins belonging to the Expansion family and a list of the entries included in the alignment are
given as Supporting Information. The elements of secondary structure corresponding to the Expansion N-MH2 domain are highlighted at the top of the
alignment, with the elements of secondary structure labelled. The results of the secondary-structure prediction used to guide us in the deﬁnition of the
protein boundaries are shown below. For comparison, the secondary-structure elements corresponding to the human Smad2 domain are depicted below
the alignment. (b) Schematic representation of the domain organization in Smad proteins and Expansion, indicating the boundaries of the prepared N-
MH2 constructs.
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removes nonconserved loops (http://www.phenix-online.org/
documentation/reference/ensembler.html). The ensemble and
the ﬁnal model are superimposed and displayed in Supple-
mentary Fig. S1.
Initial molecular-replacement solutions were rebuilt using
Rosettamodel completion and relaxation in phenix.mr_rosetta,
and automated rebuilding yielded the best results starting
from Smad2 MH2 (PDB entry 1khx), which resulted in a
model with a free R factor of 30%.
Reﬁnement was performed with phenix.reﬁne (Afonine
et al., 2012) employing simulated-annealing and energy-
minimization cycles. Initially tight geometry restraints were
applied, which were released gradually as the Rwork and Rfree
factors diverged. After several rounds of iterative reﬁnement
and model building in OMIT maps (Terwilliger et al., 2008)
and feature-enhanced maps (FEMs; Afonine et al., 2015) in
Coot (Emsley & Cowtan, 2004), density representing the
N-terminal helix of the molecule could easily be identiﬁed
in a difference electron-density map (mFo  DFc). Iterative
reﬁnement and model building was continued until no
signiﬁcant improvement in R factors could be obtained.
The reﬁned model was validated using MolProbity (Chen
et al., 2010) and the wwPDB Validation Server (http://
wwpdb-validation.wwpdb.org; Berman et al., 2003). The
Ramachandran plot is shown in Supplementary Fig. S2.
2.9. Structural analysis
Structural superimposition was performed with the super-
pose algorithm in PyMOL (Schro¨dinger) based on the
-strand content of each structure as calculated by DSSP
(Kabsch & Sander, 1983). Sequence alignments with the
EMBOSS Needle algorithm returned values for sequence
identity and similarity (Rice et al., 2000).
3. Results and discussion
3.1. Identification of a non-Smad MH2-like domain in
protostomes
The sequence identity of the Exp/Reb Drosophila proteins
(also known as CG13188 and CG13183, respectively) is mostly
restricted to the MH2 domain (30%). A comparison with
Smads reveals a similarity about 16%, which is limited to the
MH2 domain. This similarity suggests that the Exp/Reb and
Smads proteins share the presence of the MH2 domain and
that the Exp/Reb proteins may constitute a new protein family
with a specialized function in a subset of metazoan phyla.
To clarify this issue, we searched the Ensembl Metazoa
database (http://metazoa.ensembl.org) using PSI-BLAST with
the Expansion full-length sequence as the query. Our search
retrieved two sets of matches. The ﬁrst set reﬂects similarity to
the entire query in nematodes, arthropods and other hexa-
pods, suggesting the presence of orthologous proteins in these
organisms. The second set reﬂects similarity of the N-terminal
part of the sequence query to only the C-terminal part of
Smads, speciﬁcally to the MH2 domain, as reported in the
annotation of these proteins in the NCBI database. Remark-
ably, the similarity in the Exp/Reb subfamily covers an addi-
tional region of similarity preceding the canonical MH2
domain which is absent in the Smad sequences. The alignment
comparing the sequences of the Exp/Reb domains with those
of the MH2 domain of Smads is shown in Fig. 1(a).
Secondary-structure predictions using NetSurfP (Petersen
et al., 2009) corroborated the sequence similarity of the new
domain to that of the Smad MH2 structure and indicated that
the additional conserved region preceding the canonical MH2
fold might adopt a helical structure. Of the two predicted
helices, the sequence that lies adjacent to the canonical MH2
domain is more conserved than the fragment predicted at the
most N-terminal part of the protein. The prediction is depicted
at a 0.4 level of probability in the sequence alignment (Fig. 1a).
A schematic representation of the domain organization of the
Exp/Reb proteins and the similarity to Smads is shown in
Fig. 1(b). An alignment based on the full sequence of the
Expansion proteins is shown in Supplementary Fig. S3.
3.2. Drosophila Exp/Reb do not participate in the TGF-b
pathway
In addition to the structural work, we investigated the
functional implication of this new family of proteins using
cellular and genetic approaches in Drosophila. The TGF-
signalling pathway has been shown to play a key role in
tracheal formation, specifying the most dorsal and ventral
branches (Llimargas & Casanova, 1997; Ribeiro et al., 2002;
Vincent et al., 1997). When the pathway is downregulated (by
overexpressing the inhibitory Smad), the formation of dorsal
and ventral tracheal branches is compromised. However,
when the pathway is constitutively activated (by over-
expressing a constitutively active Thick Veins receptor;
TkvCA) all branches migrate along the dorso–ventral axis
(Supplementary Figs. S4a, S4b and S4c). We have observed
that the pattern of dorsal and ventral branches was correct
not only when Exp/Reb were downregulated using RNAi
(Supplementary Figs. S4d and S4e) but also when both genes
were removed using a combination of chromosome deﬁ-
ciencies that uncovers both of them (Supplementary Fig. S4f).
In fact, we detected a completely different phenotype in loss-
of-function conditions for these genes (Supplementary Figs.
S4d, S4e and S4f), related to the accumulation of an apical
chitinous extracellular matrix (aECM; Arau´jo et al., 2005;
Devine et al., 2005; Tonning et al., 2005; Moussian et al., 2015).
To further test any possible involvement of Exp/Reb in the
TGF- pathway, we also analyzed the phenotypes of their
downregulation in the wing (also obtaining a negative effect)
and compared them with the defects in the downregulation of
the control Smad4/Medea. As depicted in Supplementary Figs.
S4(g), S4(h) and S4(i), the detected phenotypes of Exp/Reb
downregulation are very different from those of the control,
conﬁrming that Exp/Reb do not appreciably transduce TGF-
signals. Our results are consistent with recently reported
experiments (Iordanou et al., 2014) and suggest that this new
family of proteins are involved in different functional path-
ways to the canonical TGF- pathway.
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Overall, these results support our hypothesis that the Exp/
Reb proteins deﬁne a new family of proteins speciﬁc for
protostomes that have the MH2 domain in common with
Smads.
3.3. Recombinant expression and structural determination of
the Na-MH2 domain of an Exp/Reb protein
3.3.1. Protein expression, NMR and crystallographic
screening. Based on the sequence conservation and on the
secondary-structure predictions, we selected two different
domain boundaries for structural studies: a construct including
the most conserved predicted helix (amino acids 29–240) and a
second construct comprising nearly the full N-terminal region
of the protein (amino acids 3–240) (Fig. 1b). These two
recombinant proteins were soluble and eluted as monomers
in size-exclusion chromatography (Supplementary Fig. S5).
According to NMR experiments the construct consisting of
amino acids 29–240 was folded (Supplementary Fig. S6), and
the initial crystallographic results were obtained using this
construct. Since diffraction-quality crystals were also obtained
from the larger construct, we focused the structural work on
this construct consisting of amino acids 3–240. This would
allow us to elucidate the role of the entire N-terminal region.
Diffraction data were collected from a monoclinic wedge-
shaped crystal with approximate dimensions of 10  30 
150 mm. The data were processed in space group P21 to a
maximum resolution of 1.6 A˚. Matthews coefﬁcient analysis
indicated a solvent content of 27% for one protomer
(28 kDa) in the asymmetric unit, which was consistent with
the tight packing observed in the structure.
3.3.2. Structural determination of the Na-MH2 domain.
Owing to the anticipated structural resemblance of the new
domain to the canonical Smad MH2 domain, we ﬁrst
attempted to solve the structure by conventional molecular
replacement (MR) using Phaser (McCoy et al., 2007) with
several human Smad MH2 domains as search models
(Table 2). Using this program we could identify a few potential
MR solutions that could not be further reﬁned, probably
owing to the low sequence identity between the Expansion
MH2 domain and human Smad MH2 (16%; Schwarzenba-
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Table 2
Human Smad MH2 domains used as search models for MR.
PDB code Description Identity (%)
1khx Human SMAD2 MH2 domain 16
1mjs Human SMAD3 MH2 domain 16
1khu Human SMAD1 MH2 domain 15
1dd1 Human SMAD4 MH2 domain 15
3gmj D. melanogaster MAD MH2 domain 14
Figure 2
Structure of the Expansion N-MH2 domain and its comparison with the human Smad2 (huSmad2) and Smad4 (huSmad4) MH2 domains. (a) Reﬁned
structure of the Expansion N-MH2 domain including residues 27–236. The structure is displayed as a cartoon representation. Elements of secondary
structure are labelled according to the Smad canonical MH2 fold, despite differences in the secondary-structure content in the N-terminus (the N helix
present in Expansion) and in the region of 2 and 8+9. (b) Superposition of the huSmad2 MH2 domain (PDB entry 1mjs; grey), the human Smad4 MH2
domain (PDB entry 1dd1; orange) and the reﬁned structure of the N-MH2 domain of Expansion (PDB entry 4r9p; blue). This view is rotated by 90
with respect to (a). (c) Close-up view of the N helix of the Expansion N-MH2 domain. The N helix (depicted in salmon) and the side chains that
contribute to its packing are represented as sticks and labelled. (d) Cartoon and electrostatic potential surface distribution of the Expansion N-MH2
domain. (e) Same as in (d) for the huSmad2 MH2 domain (PDB entry 1khx). The L3 region required for phosphorylation recognition is highlighted. ( f )
The C trace of the N-MH2 domain and electron-density maps at contour levels of 1 (0.3186 e A˚3) and 2 (0.6372 e A˚3). All ﬁgures were prepared
using PyMOL (Schro¨dinger).
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cher et al., 2004). Among these solutions, the best was that
obtained using the human Smad3 MH2 domain (PDB entry
1mjs). The selected solution (using Phaser) reported values of
LLG = 56.1, TFZ = 4.3 and Rval = 58.5 at 3 A˚ resolution, and
allowed us to partially trace the map. However, we were
unable to perform rigid-body reﬁnement as we could not
improve the R factors beyond Rwork = 0.5207 and Rfree =
0.5215. Similar values were obtained for other resolution
ranges.
Since this approach was unsuccessful, we decided to apply
the MR-Rosetta algorithm, which has recently been demon-
strated to facilitate molecular replacement in cases where only
search models of low sequence identity are available. Using
the methods compiled in the MR-Rosetta pipeline (DiMaio et
al., 2011; Terwilliger et al., 2012) from the PHENIX package
(Adams et al., 2010) and an ensemble constructed from the
known structures of canonical MH2 domains as a search
model, a structural solution could be obtained. The ensemble
and the ﬁnal model are displayed in Supplementary Fig. S1.
The data were cut following the recent recommendations by
Karplus & Diederichs (2012) at a conservative resolution of
CC1/2 > 0.5, which resulted in the data-collection and model-
reﬁnement statistics reported in Table 1. The high-quality
diffraction data allowed the modelling of residues 27–236, with
Rwork = 0.1765 and Rfree = 0.1977.
As expected, the reﬁned model revealed a tertiary structure
with a striking resemblance to the canonical Smad MH2 fold
(Figs. 2a and 2b). The structure comprises a -sandwich core
of twisted antiparallel -sheets capped at one end by a three-
helix bundle and at the other by a region containing an -helix
and several loops. In Smad MH2 domains this region is
commonly referred to as the ‘loop–helix region’ (Shi et al.,
1997).
At a ﬁrst glance, the most obvious structural difference
when superimposed on Smad2 MH2 domains is the presence
of the N helix, which is formed by the N-terminal residues
34–47 and covers one side of the core -sandwich (Figs. 2c and
2d). This new element of secondary structure is named N to
indicate its position at the N-terminus of the domain and, most
importantly, to maintain the canonical nomenclature of MH2
domains (Fig. 2c). A C trace of the N-MH2 domain and the
electron-density map at contour levels of 1 and 2 are shown
in Fig. 2( f). A few additional structural differences are
observed in the length of the helices that form the helical
bundle and in the area adjacent to the ‘loop–helix region’
comprised of helix 2, a loop and strand 8, referred to here as
the ‘H2 region’ (Fig. 2b, green rectangles). Also signiﬁcant is
the reduced length of the L3 loop that connects 10 and 11.
This loop in Smad MH2 domains comprises an interaction
motif for phosphorylated residues, and is fundamental to
receptor binding and to the
quaternary structure and function
of the Smad proteins (Lo et al.,
1998). In Smad domains loop L3
comprises 17 residues, whereas in
Expansion this loop is shorter (11
residues) and is very different in
sequence (Fig. 1a). To observe
the effect of the differences in
and around the L3 area, we have
represented the surface charge
distribution of the Expansion N-
MH2 domain and that of Smad2
for comparison (Figs. 2d and 2e)
and highlighted the presence of
positively charged patches in the
Smad2 MH2 domain that are
absent in Expansion.
3.3.3. The structure of the Na-
MH2 domain does not support
the formation of homotrimers or
heterotrimers. The N-terminal
helix observed in Expansion N-
MH2 (Figs. 2a and 2c) is a new
addition to the canonical MH2
fold characteristic of Smad
proteins. This novel structural
element packs against and inter-
acts with the triple-helical bundle
and covers the outer surface of
the -sandwich core, which
represents the interface between
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Figure 3
Comparison of the huSmad2 MH2 homotrimer with the Expansion N-MH2 domain. (a) Structural
superposition of Expansion N-MH2 (blue) and the huSmad2 MH2 homotrimer. Smad2 MH2 domains in
the trimer are represented as cartoons coloured three shades of grey to distinguish each monomer in the
homotrimeric structure. The structures are superimposed using the -sandwich (r.m.s.d. of 0.636 A˚ on 43 C
atoms). All elements of secondary structure of Expansion and of one monomer of the human Smad2 trimer
overlap, but the N helix of Expansion is superimposed on a loop of an adjacent MH2 domain of huSmad2.
The superimposed N helix and the H2 region are marked with rectangles (gold and green, respectively).
Detailed views of these regions are shown in (b) and (c).
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adjacent monomers in the functional trimer of the Smad
proteins. Previous results have suggested how cancer-derived
mutations, which map to the same area in the Smad proteins,
inhibit the formation of the functional heterotrimer (Shi et al.,
1997). When superposing the N-MH2 domain (shown in blue
in Figs. 3a, 3b and 3c) onto one monomer of the Smad2 MH2
homotrimer (shown in light grey), the N helix overlaps with
the area occupied by the ‘loop–helix region’ of the adjacent
monomer in the trimer (in the ﬁgure this second MH2 is
shown in dark grey). This structural ‘clash’ most certainly
compromises the formation of homotrimers by the N-MH2
domain in a manner similar to that observed for the Smad
MH2 domains. Furthermore, it will also prevent the formation
of heterotrimers with the MH2 domain of Smad proteins.
In Smad proteins, where the MH2 domain is located at the
protein C-terminus (Fig. 1b), the linker preceding the MH2
domain does not adopt a deﬁned tertiary structure. However,
in several structures of Smad complexes segments of the linker
have been observed to adopt different conformations when
folding upon interaction with other proteins (Arago´n et al.,
2011, 2012; Shi & Massague´, 2003).
The secondary-structure predictions of the Expansion
family of proteins suggested the presence of a second helix at
the very N-terminus of the protein (Fig. 1a). However, no
electron density could be observed for this predicted helix,
likely reﬂecting a degree of ﬂexibility in this area. Patches of
positive electron density observed in a difference-density map
(mFo  DFc) suggested that the region comprising the ﬁrst 24
residues extends into a solvent channel of the crystal structure;
however, any effort to improve the model in this region did
not improve the reﬁnement statistics and the model was
therefore truncated at the N-terminus.
3.3.4. Protein interactions in MH2 domains. The divergent
sequence of loop L3 in the N-MH2 domain indicates a
signiﬁcant difference in the function of the Expansion N-
MH2 domain with respect to canonical Smad MH2 domains.
In the TGF- pathway signals are propagated through
receptor activation of R-Smads by phosphorylation of the
S-X-S motif at the C-terminus of the MH2 domain, leading
to heterotrimer formation through the MH2 domain of two
R-Smads with the common Smad4. Formation of the hetero-
trimer triggers the subsequent translocation of Smads to the
nucleus. Mutations in the L3 loop of the Smad proteins abolish
the formation of heterotrimers and hence signalling in the
TGF- pathway (Wu et al., 2001). Whereas unphosphorylated
Smad proteins are able to form dimers and trimers in a
concentration-dependent manner (Shi & Massague´, 2003), the
presence of the additional helix and the lack of the L3 loop in
the N-MH2 domain could effectively prevent this domain
from supporting the formation of similar dimers and trimers.
The Smad MH2 domain is commonly known to support
protein interactions, and interestingly the overall composition
of the Expansion N-MH2 domain remains largely the same
despite the low degree of sequence identity. However, the H2
region that has been established as a protein–protein inter-
action site in Smad proteins (Qin et al., 1999; Wu et al., 2002) is
completely different in the Expansion N-MH2 domain. In
the reﬁned model of the N-MH2 domain the -sandwich core
is comprised by two antiparallel -sheets each having ﬁve
strands, whereas in Smad MH2 the upper sheet comprises six
strands (Figs. 2a and 2b). In the Expansion N-MH2 domain
the region of amino acids 162–165 that would correspond to
the 8 strand in Smads lacks a deﬁned secondary structure; it
instead bears characteristics of random coil similar to most of
the adjacent H2 region, apart from helix 2. In Smad proteins
the H2 region extends from strand 7 in the upper -sheet,
with helix 2 followed by a short loop that connects to strand
8 continuing to strand 9. In the N-MH2 domain strand 7
is followed by a large loop connected to a reoriented helix 2,
followed by an extended region (corresponding to strand 8)
continuing to strand 9 (Figs. 2a and 2b).
In the Smad proteins the H2 region and the 8 strand
are implicated in protein–protein interactions by -sheet
augmentation, similar to common PDZ domains (Cowburn,
1997; Doyle et al., 1996; Morais Cabral et al., 1996; Schultz et
al., 1998), by annealing an additional -strand to an existing
-sheet. This type of coordination is common in protein–
protein interactions (Remaut &Waksman, 2006) and has been
characterized structurally in three cases for Smad proteins.
The structure of the isolated human Smad4 MH2 domain
was solved from a construct with a protracted N-terminal
boundary containing the ﬁrst part of the linker region (for the
‘common’ Smad4 this is also known as the Smad-activation
domain). As mentioned above, the structure revealed that part
of the linker adopts an extended conformation and interacts
with the H2 region by -sheet augmentation (PDB entry 1dd1;
Qin et al., 1999). Similarly, the structure of Smad4 in complex
with the repressor protein c-Ski (PDB entry 1mr1) also shows
that the interaction occurs through -sheet augmentation of
strand 8 (Wu et al., 2002). Moreover, the interaction between
Smad2 and SARA (Smad anchor for receptor activation) has
been characterized structurally and was also revealed to
involve -sheet augmentation, but not in the H2 region (PDB
entry 1dev; Wu et al., 2000). It is possible that secondary-
structural changes induced by ligand binding could stabilize
the 8 structure. Indeed, NetSurfP predicts the presence of
strand 8 in Expansion, indicating (to some extent) an
intrinsic folding property of this area. Of interest in the
remodelling of the H2 region of the Expansion N-MH2
domain as a potential protein-interaction site is the consid-
eration of the degree of speciﬁcity that this remodelling might
provide.
3.3.5. Structural classification in the Smad/FHA family.
Structural homology to the Smad MH2 domain has also been
found in FHA domains and the C-terminal regulatory domain
of IRF-3. Despite a complete absence of sequence conserva-
tion between these proteins, an evolutionary link has
previously been suggested owing to the structural and distant
functional similarities between the -sandwiches in these
proteins (Durocher et al., 2000; Huse et al., 2001; Takahasi et
al., 2003). Indeed, these proteins have all been classiﬁed into
the same SCOP superfamily: the Smad/FHA domain. The
superimposed structures of the human MDC1 FHA domain,
the C-terminal regulatory domain of IRF-3 and the Expansion
research papers
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N-MH2 domain are shown in Supplementary Fig. S7. Since
the MH2 domain of Smads is similar to the IRF-3 regulatory
domain and to the FHA domain, the N-MH2 domain of
Expansion is also a member of the same family of structures.
IRF proteins are only found in vertebrates, whereas the
Smad MH2 domain and the FHA domain co-exist in
metazoans and the FHA domain is also found in prokaryotes.
Durocher et al. (2000) found the minimal -sandwich of the
FHA domain to comprise alternative protein-interaction sites,
similar to those identiﬁed in the Smad MH2 domain, and
Takahasi et al. (2003) speculated that the different ﬂanking
regions of the -sandwich in the C-terminal regulatory domain
of IRF-3 and Smad-MH2 developed on the -sandwich scaf-
fold of the FHA protein to facilitate phosphorylation signal-
ling in higher organisms.
4. Conclusions
We have determined the structure of the N-MH2 domain
present in Expansion at 1.6 A˚ resolution. The addition of the
N-terminal helix, the differences in the L3 loop and its lack of
a role in the canonical TGF- signalling pathway support the
classiﬁcation of Expansion as a new family of proteins that
share the presence of the MH2 domain with Smads. Further-
more, the structural differences between the Smad MH2 and
Expansion N-MH2 domains could have evolved to host a
different range of protein-interaction partners, with implica-
tions for different cellular functions which apparently have
been conserved in protostomes (Mollusca, Annelida and
Arthropoda phyla).
For these reasons, we suggest that Expansion should not be
termed a ‘Smad-like’ protein. Furthermore, we propose that
the Smad/FHA family of structures should be ‘expanded’ to
also include the Expansion N-MH2 domain.
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